TruScreen's real time technology has been found to be twice as sensitive as the Pap test and significantly more sensitive than HPV DNA testing at defining high grade cervical lesions in a real world setting.

Truscreen Unit

Millions of women worldwide are unable to access cervical cancer screening.

Millions of women worldwide are unable to access cervical cancer screening.

Current pap smear testing is not effective in low-resource or developing health economies due to the lack of infrastructure and the highly trained personnel required to read the smear, as well as delays in reporting results, particularly in remote locations. More than 270,000 women die from this disease each year.

Learn more

Cervical cancer is a major cause of morbidity and mortality worldwide.

Cervical cancer is a major cause of morbidity and mortality worldwide.

It is the second largest cause of deaths due to cancer in women. The death toll is greatest in populations that lack cervical cancer screening programmes. Worldwide, there are approximately 500,000 new cases of cervical cancer diagnosed and more than 270,000 die from this disease each year.

Learn more

TruScreen has been clinically tested by over 10,000 women around the world.

TruScreen has been clinically tested by over 10,000 women around the world.

Studies have involved women from Australia, Brazil, Italy, Philippines, People’s Republic of China, Russia, Singapore, South Africa, Spain, United Kingdom and the United States of America. More than 17 clinical trials involving 10,000 women have been completed worldwide.

Learn more

Better access to cervical cancer screening will save thousands of lives.

Better access to cervical cancer screening will save thousands of lives.

Cervical cancer develops from slowly progressing intraepithelial lesions. If early changes in cervical cells are detected through screening programmes, cervical cancer is curable. However, if undetected until late in its clinical course, it has a high death rate.

Learn more

TruScreen supports cervical screening in remote areas and developing countries.

TruScreen supports cervical screening in remote areas and developing countries.

For many women in remote areas and developing countries, poor access to cervical screening in clinics means many women go undetected until it is too late. TruScreen provides mobile units which are easy to use and do not require lab facilities in order to diagnose women.

Learn more

TruScreen performs equal to, or better than, alternative cervical screening tools.

TruScreen performs equal to, or better than, alternative cervical screening tools.

The performance of TruScreen has been tested in 17 clinical trials involving 10,000 women worldwide and was consistent and equal to, or better than in some studies, the comparing high quality cytology tests within the same study.

Learn more

TruScreen’s world-class technology has the power to save lives

TruScreen is a cost-effective test that can be used outside existing laboratory infrastructure and has high potential to aid in reducing cervical cancer mortality.

TruScreen has been extensively evaluated in studies involving more than 10,000 women worldwide. In our most recent study, in Guadalajara, Mexico, TruScreen was found to be more than twice as sensitive as the Pap smear in identifying both low grade and high grade cervical lesions.

TruScreen’s sensitivity for high grade lesions was 78% compared to the Pap test at 36% and the HPV DNA at 56%. The negative predictive value for all pre-cancerous changes was 95%.

More importantly TruScreen’s Gen II device, during performance evaluation at the Royal Hospital for Women in Sydney, Australia, has correctly identified 100% high grade lesions presented to date.

Unlike the Pap test, tissue samples are not collected, which minimises discomfort for patients. This new technology detects pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. The system uses low levels of electricity and light to examine the cervix as a hand-held wand is gently moved over the surface of the cervix.

Learn More

Doctor
Back to top